{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-23-011418","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2023-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.826241+00:00","generated_at":"2026-06-11T08:33:18.242955+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Alzamend Neuro to use X and LinkedIn for material disclosures","bullets":["Company adopts X (Twitter) @AlzamendNeuro and LinkedIn for public communications.","Cites SEC Release No. 69279 on social media disclosure of material non-public info.","Encourages investors to monitor social media alongside website, SEC filings, and press releases."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-23-011418","json":"https://secwatch.observer/filing/0001214659-23-011418.json","markdown":"https://secwatch.observer/filing/0001214659-23-011418.md","text":"https://secwatch.observer/filing/0001214659-23-011418.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923011418/0001214659-23-011418-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923011418/j8162308k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T08:33:18.242955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}